Today, FDA issued a Drug Safety Communication announcing label changes that limit the use of pain-relieving and fever-reducing nonsteroidal anti-inflammatory drugs (NSAIDs) after around 20 weeks gestation or later in pregnancy.
Read more: FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications